Isolation and Molecular Characterization of Circulating Melanoma Cells

Cell Reports

Volumn 7, Issue 3, 2014, Pages 645-653

  Luo, Xi ^a,e   Mitra, Devarati ^b   Sullivan, Ryan J ^a,b   Wittner, Ben S ^a   Kimura, Anya M ^a   Pan, Shiwei ^a   Hoang, Mai P ^b   Brannigan, Brian W ^a   Lawrence, Donald P ^a,b   Flaherty, Keith T ^a,b   Sequist, Lecia V ^a,b   McMahon, Martin ^c   Bosenberg, Marcus W ^d   Stott, Shannon L ^a,b   Ting, David T ^a,b   Ramaswamy, Sridhar ^a,b   Toner, Mehmet ^b   Fisher, David E ^a,b   Maheswaran, Shyamala ^a,b   Haber, Daniel A ^a,b,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; B RAF KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TAMOXIFEN; N [3 (5 CHLORO 1H PYRROLO[2,3 B]PYRIDINE 3 CARBONYL) 2,4 DIFLUOROPHENYL]PROPANESULFONAMIDE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BRAF PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CELL ISOLATION; CELL MOTILITY; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; METASTATIC MELANOMA; MICROFLUIDICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; TUMOR INVASION; TUMOR LOCALIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; CANCER SURGERY; CELL INVASION; CLINICAL ARTICLE; COHORT ANALYSIS; DISTANT METASTASIS; MELANOMA CELL LINE; NUCLEOTIDE SEQUENCE; PILOT STUDY; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL SEPARATION; DRUG EFFECTS; EXPERIMENTAL MELANOMA; METABOLISM; METASTASIS; MICROFLUIDIC ANALYSIS; PATHOLOGY; SEQUENCE ANALYSIS; TUMOR CELL LINE; TUMOR EMBOLISM;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE, TUMOR; CELL SEPARATION; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROTO-ONCOGENE PROTEINS B-RAF; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS, RNA; TAMOXIFEN; TRANSCRIPTOME;

EID: 84899974076     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.039     Document Type: Article

References (34)

1. Alonso S.R., Tracey L., Ortiz P., Pérez-Gómez B., Palacios J., Pollán M., Linares J., Serrano S., Sáez-Castillo A.I., Sánchez L., et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007, 67:3450-3460.
2. Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Atkins M.B., Byrd D.R., Buzaid A.C., Cochran A.J., Coit D.G., Ding S., et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 2009, 27:6199-6206.
3. Boiko A.D., Razorenova O.V., van de Rijn M., Swetter S.M., Johnson D.L., Ly D.P., Butler P.D., Yang G.P., Joshua B., Kaplan M.J., et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010, 466:133-137.
4. Carrillo E., Prados J., Melguizo C., Marchal J.A., Vélez C., Serrano S., Boulaiz H., Mérida J.A., Aránega A. Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type. Pathol. Int. 2002, 52:294-299.
5. Cho E.H., Wendel M., Luttgen M., Yoshioka C., Marrinucci D., Lazar D., Schram E., Nieva J., Bazhenova L., Morgan A., et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys. Biol. 2012, 9:016001.
6. Damsky W.E., Curley D.P., Santhanakrishnan M., Rosenbaum L.E., Platt J.T., Gould Rothberg B.E., Taketo M.M., Dankort D., Rimm D.L., McMahon M., Bosenberg M. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 2011, 20:741-754.
7. Dankort D., Curley D.P., Cartlidge R.A., Nelson B., Karnezis A.N., Damsky W.E., You M.J., DePinho R.A., McMahon M., Bosenberg M. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 2009, 41:544-552.
8. De Giorgi V., Pinzani P., Salvianti F., Panelos J., Paglierani M., Janowska A., Grazzini M., Wechsler J., Orlando C., Santucci M., et al. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J. Invest. Dermatol. 2010, 130:2440-2447.
9. Delys L., Detours V., Franc B., Thomas G., Bogdanova T., Tronko M., Libert F., Dumont J.E., Maenhaut C. Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 2007, 26:7894-7903.
10. Fidler I.J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer 1973, 9:223-227.
11. Flaherty K.T., Hodi F.S., Fisher D.E. From genes to drugs: targeted strategies for melanoma. Nat. Rev. Cancer 2012, 12:349-361.
12. Frederick D.T., Piris A., Cogdill A.P., Cooper Z.A., Lezcano C., Ferrone C.R., Mitra D., Boni A., Newton L.P., Liu C., et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin. Cancer Res. 2013, 19:1225-1231.
13. Held M.A., Curley D.P., Dankort D., McMahon M., Muthusamy V., Bosenberg M.W. Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res. 2010, 70:388-397.
14. Herlyn M., Koprowski H. Melanoma antigens: immunological and biological characterization and clinical significance. Annu. Rev. Immunol. 1988, 6:283-308.
15. Hoek K.S., Eichhoff O.M., Schlegel N.C., Döbbeling U., Kobert N., Schaerer L., Hemmi S., Dummer R. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 2008, 68:650-656.
16. Hoshida Y., Nijman S.M., Kobayashi M., Chan J.A., Brunet J.P., Chiang D.Y., Villanueva A., Newell P., Ikeda K., Hashimoto M., et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009, 69:7385-7392.
17. Hoshimoto S., Shingai T., Morton D.L., Kuo C., Faries M.B., Chong K., Elashoff D., Wang H.-J., Elashoff R.M., Hoon D.S.B. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J. Clin. Oncol. 2012, 30:3819-3826.
18. Jeffs A.R., Glover A.C., Slobbe L.J., Wang L., He S., Hazlett J.A., Awasthi A., Woolley A.G., Marshall E.S., Joseph W.R., et al. A gene expression signature of invasive potential in metastatic melanoma cells. PLoS ONE 2009, 4:e8461.
19. Khoja L., Lorigan P., Zhou C., Lancashire M., Booth J., Cummings J., Califano R., Clack G., Hughes A., Dive C. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma. J. Invest. Dermatol. 2013, 133:1582-1590.
20. Liu Z., Fusi A., Klopocki E., Schmittel A., Tinhofer I., Nonnenmacher A., Keilholz U. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J. Transl. Med. 2011, 9:70.
21. Onken M.D., Ehlers J.P., Worley L.A., Makita J., Yokota Y., Harbour J.W. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 2006, 66:4602-4609.
22. Ozkumur E., Shah A.M., Ciciliano J.C., Emmink B.L., Miyamoto D.T., Brachtel E., Yu M., Chen P.I., Morgan B., Trautwein J., et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 2013, 5:179ra147.
23. Poola I., DeWitty R.L., Marshalleck J.J., Bhatnagar R., Abraham J., Leffall L.D. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat. Med. 2005, 11:481-483.
24. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
25. Quintana E., Piskounova E., Shackleton M., Weinberg D., Eskiocak U., Fullen D.R., Johnson T.M., Morrison S.J. Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Sci. Transl. Med. 2012, 4:159ra149.
26. Ramsköld D., Luo S., Wang Y.C., Li R., Deng Q., Faridani O.R., Daniels G.A., Khrebtukova I., Loring J.F., Laurent L.C., et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 2012, 30:777-782.
27. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., et al. Identification of cells initiating human melanomas. Nature 2008, 451:345-349.
28. Schramm S.J., Campain A.E., Scolyer R.A., Yang Y.H., Mann G.J. Review and cross-validation of gene expression signatures and melanoma prognosis. J. Invest. Dermatol. 2012, 132:274-283.
29. Schuetz C.S., Bonin M., Clare S.E., Nieselt K., Sotlar K., Walter M., Fehm T., Solomayer E., Riess O., Wallwiener D., et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 2006, 66:5278-5286.
30. Smith A.P., Hoek K., Becker D. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol. Ther. 2005, 4:1018-1029.
31. Stott S.L., Hsu C.H., Tsukrov D.I., Yu M., Miyamoto D.T., Waltman B.A., Rothenberg S.M., Shah A.M., Smas M.E., Korir G.K., et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. USA 2010, 107:18392-18397.
32. Su F., Viros A., Milagre C., Trunzer K., Bollag G., Spleiss O., Reis-Filho J.S., Kong X., Koya R.C., Flaherty K.T., et al. RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N. Engl. J. Med. 2012, 366:207-215.
33. Yu M., Stott S., Toner M., Maheswaran S., Haber D.A. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 2011, 192:373-382.
34. Yu M., Ting D.T., Stott S.L., Wittner B.S., Ozsolak F., Paul S., Ciciliano J.C., Smas M.E., Winokur D., Gilman A.J., et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012, 487:510-513.